Cernostics

A life science company developing new molecular diagnostic tests to treat cancer.

Launch date

2008

Employees

Market cap

Enterprise valuation

€27m (Public information from Oct 2021)

Pittsburgh Pennsylvania (HQ)

Date	Investors	Amount	Round
-	Pittsburgh Life Sciences Greenhouse Geisinger Ventures Small Business Innovation Research (SBIR) US Department of Health and Human Services	N/A	-
Mar 2012	N/A	N/A	Seed
Aug 2012	N/A	N/A	Seed
Dec 2012	Ben Franklin Technology Partners	N/A	Debt
Jul 2013	Novitas Capital	$1.4m	Seed
Dec 2013	Geisinger Health System	$1.4m	Series B
Jun 2015	Ben Franklin Technology Partners Ben Franklin Technology Partners of Central and Northern Pennsylvania	$2.0m	Early VC
Aug 2016	The University of Pittsburgh Medical Center UPMC Enterprises	$5.0m	Early VC
Mar 2018	Illumina Ventures	$2.5m	Series A
Aug 2021	N/A	$6.0m	Early VC
Oct 2021	Castle Biosciences	$30.0m Valuation: $30.0m	Acquisition
Total Funding		€19.7m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Cernostics